NCT04445948View on ClinicalTrials.gov

Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

June 21, 2020

Study Completion Date

June 21, 2020

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole 40 milligrams Oral Tablet

Proton Pump inhibitor

DRUG

Amoxicillin 1000 milligrams tablets

Penicillin derivative antibiotic

DRUG

Clarithromycin 500 milligrams Tablets

Macrolide antibiotic

DRUG

MetroNIDAZOLE 500 milligrams Oral Tablet

Antiprotozoal

DRUG

Lactoferrin Bovine sachets 200 milligrams

a protein found naturally in milk from humans and cows

Trial Locations (1)

21521

Faculty of Medicine, Alexandria

All Listed Sponsors
collaborator

University of Alexandria

OTHER

lead

Alexandria University

OTHER

NCT04445948 - Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy | Biotech Hunter | Biotech Hunter